Karen Prange
Direktor/Vorstandsmitglied bei ATRICURE, INC.
Vermögen: 971 683 $ am 30.04.2024
Profil
Karen Naomi Prange is currently serving as an Independent Director in AtriCure, Inc., ViewRay, Inc., Nevro Corp., WS Audiology A, and Embecta Corp.
She is also a Member of The Committee of 200.
In the past, she served as EVP and CEO-Global Animal Health & Medical Group in Henry Schein, Inc., Independent Director in Cantel Medical LLC, GM-Micrus Endovascular & Codman Neurovascula in Johnson & Johnson, and SVP and President-Urology & Women's Health in Boston Scientific Corp.
Ms. Prange completed her undergraduate degree from the University of Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATRICURE, INC.
0,05% | 13.05.2024 | 23 928 ( 0,05% ) | 541 012 $ | 30.04.2024 |
EMBECTA CORPORATION
0,04% | 07.02.2024 | 24 898 ( 0,04% ) | 258 939 $ | 30.04.2024 |
NEVRO CORP.
0,04% | 25.05.2023 | 14 779 ( 0,04% ) | 171 732 $ | 30.04.2024 |
VIEWRAY, INC.
0,00% | 21.07.2023 | 8 799 ( 0,00% ) | - $ | 30.04.2024 |
Aktive Positionen von Karen Prange
| Unternehmen | Position | Beginn |
|---|---|---|
| ATRICURE, INC. | Direktor/Vorstandsmitglied | 04.12.2019 |
| NEVRO CORP. | Direktor/Vorstandsmitglied | 17.12.2019 |
| VIEWRAY, INC. | Direktor/Vorstandsmitglied | 11.06.2021 |
| EMBECTA CORP. | Direktor/Vorstandsmitglied | 01.04.2022 |
The Committee of 200
 The Committee of 200 Miscellaneous Commercial ServicesCommercial Services The Committee of 200 operates as a membership organization for women entrepreneurs and corporate innovators. | Corporate Officer/Principal | - |
WS Audiology A/S
 WS Audiology A/S Medical SpecialtiesHealth Technology WS Audiology A/S manufactures hearing aids. Its purpose is to operate, directly and through subsidiaries, within the development, production, and trade of medical and acoustic equipment. The firm supplies hearing care professionals and wholesalers, as well as governments, retail chains, purchasing groups, and independent retailers. The company was founded in 2019 and is headquartered in Lynge, Denmark. | Direktor/Vorstandsmitglied | 01.03.2020 |
Ehemalige bekannte Positionen von Karen Prange
| Unternehmen | Position | Ende |
|---|---|---|
| CANTEL MEDICAL CORP. | Direktor/Vorstandsmitglied | 02.06.2021 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 23.04.2018 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.05.2016 |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Karen Prange
| University of Florida | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 7 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| HENRY SCHEIN, INC. | Distribution Services |
| ATRICURE, INC. | Health Technology |
| NEVRO CORP. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| VIEWRAY, INC. | Health Technology |
| EMBECTA CORP. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
The Committee of 200
The Committee of 200 Miscellaneous Commercial ServicesCommercial Services The Committee of 200 operates as a membership organization for women entrepreneurs and corporate innovators. | Commercial Services |
Cantel Medical LLC
 Cantel Medical LLC Medical SpecialtiesHealth Technology Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Medical, Life Sciences, Dental and Dialysis. The Medical segment designs, develops, manufactures, sells and installs a comprehensive products and services comprising a complete circle of infection prevention solutions. The Life Sciences segment designs, develops, manufactures, sells and installs water purification systems for medical, pharmaceutical and other bacteria controlled applications. The Dental segment designs, manufactures, sells, supplies and distributes single-use infection prevention healthcare products, used by dental practitioners. The Dialysis segment designs, develops, manufactures, and sells reprocessing systems for dialyzers. Cantel Medical was founded on August 16, 1963 and is headquartered in Little Falls, NJ. | Health Technology |
WS Audiology A/S
WS Audiology A/S Medical SpecialtiesHealth Technology WS Audiology A/S manufactures hearing aids. Its purpose is to operate, directly and through subsidiaries, within the development, production, and trade of medical and acoustic equipment. The firm supplies hearing care professionals and wholesalers, as well as governments, retail chains, purchasing groups, and independent retailers. The company was founded in 2019 and is headquartered in Lynge, Denmark. | Health Technology |
